Your browser doesn't support javascript.
loading
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study.
Santoro, Maria Mercedes; Armenia, Daniele; Teyssou, Elisa; Santos, José Ramón; Charpentier, Charlotte; Lambert-Niclot, Sidonie; Antinori, Andrea; Katlama, Christine; Descamps, Diane; Perno, Carlo Federico; Calvez, Vincent; Paredes, Roger; Ceccherini-Silberstein, Francesca; Marcelin, Anne Geneviève.
Afiliação
  • Santoro MM; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: santormaria@gmail.com.
  • Armenia D; Saint Camillus International University of Health Sciences, Rome, Italy.
  • Teyssou E; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France.
  • Santos JR; Fight AIDS and Infectious Diseases Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Charpentier C; Service de Virologie, Université de Paris, INSERM, IAME, Hôpital Bichat-Claude Bernard, Paris, France.
  • Lambert-Niclot S; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Hôpital Universitaire Saint Antoine, laboratoire de virologie, Paris, France.
  • Antinori A; Infectious Disease-Clinical Department, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy.
  • Katlama C; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France.
  • Descamps D; Service de Virologie, Université de Paris, INSERM, IAME, Hôpital Bichat-Claude Bernard, Paris, France.
  • Perno CF; Multimodal Laboratory Research Department, Children Hospital Bambino Gesù, IRCCS, Rome, Italy.
  • Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France.
  • Paredes R; Fight AIDS and Infectious Diseases Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
  • Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, Paris, France.
J Glob Antimicrob Resist ; 31: 52-62, 2022 12.
Article em En | MEDLINE | ID: mdl-35948240

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article